NCT05325229 2022-10-13
A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2 Unknown
Clinical Trials
8 trialsNCT05158062 2022-04-26
Pembrolizumab and Bevacizumab With Chemotherapy Followed by Pembrolizumab, Bevacizumab and Olaparib in Recurrent Ovarian Cancer
Saitama Medical University International Medical Center
Phase 2 Unknown
NCT01461746 2017-05-31
Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer
Asan Medical Center
Phase 2 Unknown
NCT02703961 2016-03-17
Randomized Control Trial on Efficacy and Safety of Concurrent and Adjuvant Chemotherapy for the Cervical Cancer
Air Force Military Medical University, China
Phase 3 Unknown
NCT00003560 2014-01-06
Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01999933 2013-12-03
Evaluation of Postoperative Radiotherapy and Concurrent Chemotherapy Effectiveness in Cervical Cancer
Air Force Military Medical University, China
Phase 2/3 Unknown
NCT00075543 2008-07-24
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00551577 2007-10-31
PRIMOVAR-1
University Hospital, Bonn
Phase 2 Unknown